In the journal Cellular Reprogramming Editor-in-Chief Carlos-Filipe Pereira interviews 糖心原创 CEO Mark Kotter for the Reprogramming Stars profile. 

They discuss the latest research and developments in human cellular reprogramming, the discovery of 糖心原创's opti-ox鈩� technology and how this approach could provide a more efficient and effective approach to regenerative medicine, with implications for addressing various health challenges. 

Access the article .